Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea

American Journal of Surgical Pathology

Volumn 35, Issue 9, 2011, Pages 1274-1286

  Kim, Kyoung Mee ^a   Lee, Eui Jin ^a   Ha, Sangyun ^a   Kang, So Young ^a   Jang, Kee Taek ^a   Park, Cheol Keun ^a   Kim, Jin Yong ^a   Kim, Young Ho ^a   Chang, Dong Kyung ^a   Odze, Robert Daniel ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cancer; dysplasia; pathology; polyp; serrated adenoma

Indexed keywords

APBA1 PROTEIN, HUMAN; APBA2 PROTEIN, HUMAN; B RAF KINASE; BRAF PROTEIN, HUMAN; CADHERIN; CARRIER PROTEIN; DNA METHYLTRANSFERASE; KRAS PROTEIN, HUMAN; MGMT PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAS PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADENOMA; ADULT; AGED; ARTICLE; ASIAN; CHI SQUARE DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL TRIAL; COLON POLYP; COLORECTAL TUMOR; COMPARATIVE STUDY; DNA METHYLATION; ETHNOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERPLASIA; INTESTINE POLYP; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MULTICENTER STUDY; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION; RECTUM DISEASE; SOUTH KOREA; STATISTICAL MODEL; TUMOR SUPPRESSOR GENE; UNITED STATES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMA; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CADHERINS; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; GENES, P16; HUMANS; HYPERPLASIA; INTESTINAL POLYPS; LINEAR MODELS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RECTAL DISEASES; REPUBLIC OF KOREA; TUMOR SUPPRESSOR PROTEINS; UNITED STATES; YOUNG ADULT;

EID: 80052348969     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318224cd2e     Document Type: Article

References (44)

1. Bartley AN, Thompson PA, Buckmeier JA, et al. Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps. Mod Pathol 2010;23:169-76.
2. Buhard O, Suraweera N, Lectard A, et al. Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis Markers. 2004;20:251-257. (Pubitemid 40164097)
3. Capel E, Flejou JF, Hamelin R. Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis. Oncogene. 2007;26:7596-7600. (Pubitemid 350207716)
4. Carr NJ, Mahajan H, Tan KL, et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol. 2009;62:516-518.
5. Chan TL, Zhao W, Leung SY, et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 2003;63:4878-4881. (Pubitemid 37022620)
6. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a highthroughput assay to measure DNA methylation. Nucleic Acids Res. 2000;28:E32.
7. Eads CA, Lord RV, Wickramasinghe K, et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 2001;61:3410-3418. (Pubitemid 32695034)
8. Farris AB, Misdraji J, Srivastava A, et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol. 2008;32:30-35.
9. Fugita K, Yamamoto H, Matsumoto T, et al. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol 2011;35(2):295-304.
10. Gibson JA, Hahn HP, Shahsafaei A, et al. MUC Expression in Hyperplastic and Serrated Colonic Polyps: lack of Specificity of MUC6. Am J Surg Pathol. 2011 (In Press).
11. Goel A, Nagasaka T, Hamelin R, et al. An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers. PLoS One. 2010;5:e9393.
12. Goel A, Xicola RM, Nguyen TP, et al. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2010;138:1854-1862.
13. Goldstein NS. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol. 2006;125:146-153. (Pubitemid 43089737)
14. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821-9826. (Pubitemid 26296693)
15. Iino H, Jass JR, Simms LA, et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol. 1999;52:5-9. (Pubitemid 29023500)
16. Jass JR. Hyperplastic polyps of the colorectum-innocent or guilty? Dis Colon Rectum. 2001;44:163-166.
17. Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol. 2001;193:283-285. (Pubitemid 32229857)
18. Jass JR. Serrated adenoma of the colorectum and the DNAmethylator phenotype. Nat Clin Pract Oncol. 2005;2:398-405. (Pubitemid 43115008)
19. Jass JR, Baker K, Zlobec I, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology. 2006;49:121-131. (Pubitemid 44079695)
20. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137-1144. (Pubitemid 38961968)
21. Kim KM, Kim H, Chi HS, et al. Comparison of antiplatelet potency of sarpogrelate, aspirin, and beraprost in healthy volunteers according to in-vitro closure time. Blood Coagul Fibrinolysis. 2010;21:262-265.
22. Kim YH, Kakar S, Cun L, et al. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer. 2008;123:2587-2593.
23. Lauwers GY, Chung DC. The serrated polyp comes of age. Gastroenterology. 2006;131:1631-1634. (Pubitemid 44708958)
24. Lee SK, Chang HJ, Kim TI, et al. Clinicopathologic findings of colorectal traditional and sessile serrated adenomas in Korea: a multicenter study. Digestion 2008;77:178-183.
25. Lee S, Cho NY, Choi M, et al. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathol Int. 2008;58:104-113.
26. Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2007;50:131-150. (Pubitemid 44953404)
27. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol. 2009;4:343-364.
28. O'Brien MJ, Yang S, Clebanoff JL, et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004;28:423-434. (Pubitemid 38436515)
29. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491-1501. (Pubitemid 44808785)
30. Owens SR, Chiosea SI, Kuan SF. Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol. 2008;21:660-669. (Pubitemid 351744844)
31. Park SJ, Rashid A, Lee JH, et al. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol. 2003;162: 815-822. (Pubitemid 36237490)
32. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837-845. (Pubitemid 41242676)
33. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low-and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". Am J Clin Pathol. 2006;126:564-571. (Pubitemid 44498506)
34. Snover DC. Serrated adenomas. Am J Clin Pathol. 2005;124: 611-612. [author reply 612-615].
35. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2010;42:1-10.
36. Snover DC, Jass JR, Fenoglio-Preiser C, et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380-391. (Pubitemid 41232924)
37. Snover D, Ahnen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Carneiro F, Flejou JF, ed. WHO Classification of Tumours of the Digestive System. 4th Ed. Lyon: IARC Press; 2010:160-5.
38. Song KB, Atkinson C, Frankenfeld CL, et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr. 2006;136:1347-1351.
39. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131: 1400-1407. (Pubitemid 44708940)
40. Torlakovic E, Skovlund E, Snover DC, et al.Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65-81. (Pubitemid 36014900)
41. Vaughn CP, Wilson AR, Samowitz WS. Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol. 2010;23:151-156.
42. Wynter CV, Walsh MD, Higuchi T, et al. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut. 2004;53:573-580. (Pubitemid 38372984)
43. Yang S, Farraye FA, Mack C, et al. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28:1452-1459. (Pubitemid 39425511)
44. Yashiro M, Laghi L, Saito K, et al. Serrated Adenomas Have a Pattern of Genetic Alterations That Distinguishes Them from Other Colorectal Polyps. Cancer Epidemiol Biomarkers Prev. 2005;14: 2253-2256. (Pubitemid 41603275)